Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ahura Scientific was a pioneer in the development of handheld Raman and FTIR spectroscopic instruments designed for the rapid, non-destructive identification of chemicals and pharmaceutical raw materials. The company's flagship products, TruScan and FirstDefender, became industry standards for pharmaceutical quality control and first responder safety by enabling through-container analysis. This technology significantly streamlined the raw material verification process in GMP manufacturing environments, reducing the need for traditional laboratory testing. In 2010, the company was acquired by Thermo Fisher Scientific for approximately $145 million. Today, its technology remains a core component of Thermo Fisher's portable analytical instrument portfolio, serving the global life sciences and defense sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ahura.